171 related articles for article (PubMed ID: 30149280)
21. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoids in hair: strategy to prove marijuana/hashish consumption.
Uhl M; Sachs H
Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086
[TBL] [Abstract][Full Text] [Related]
23. A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids.
Hädener M; Vieten S; Weinmann W; Mahler H
Forensic Sci Int; 2019 Feb; 295():207-212. PubMed ID: 30638755
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking.
Skopp G; Pötsch L
J Anal Toxicol; 2008 Mar; 32(2):160-4. PubMed ID: 18334100
[TBL] [Abstract][Full Text] [Related]
25. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
Jones AW; Holmgren A; Kugelberg FC
Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
[TBL] [Abstract][Full Text] [Related]
26. Validity testing of the accuPINCH THC test.
Jenkins AJ; Darwin WD; Huestis MA; Cone EJ; Mitchell JM
J Anal Toxicol; 1995; 19(1):5-12. PubMed ID: 7723303
[TBL] [Abstract][Full Text] [Related]
27. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson E; Halldin MM
J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
[TBL] [Abstract][Full Text] [Related]
28. The effect of antioxidants on the long-term stability of THC and related cannabinoids in sampled whole blood.
Sørensen LK; Hasselstrøm JB
Drug Test Anal; 2018 Feb; 10(2):301-309. PubMed ID: 28570781
[TBL] [Abstract][Full Text] [Related]
29. Analysis of cannabinoids in urine samples of short-term and long-term consumers of hemp seed products.
Baeck S; Kim B; Cho B; Kim E
Forensic Sci Int; 2019 Dec; 305():109997. PubMed ID: 31670217
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
[TBL] [Abstract][Full Text] [Related]
31. Fitness to drive and cannabis: validation of two blood THCCOOH thresholds to distinguish occasional users from heavy smokers.
Fabritius M; Augsburger M; Chtioui H; Favrat B; Giroud C
Forensic Sci Int; 2014 Sep; 242():1-8. PubMed ID: 24999608
[TBL] [Abstract][Full Text] [Related]
32. Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability.
Gelmi TJ; Weinmann W; Pfäffli M
Forensic Sci Res; 2021; 6(3):195-207. PubMed ID: 34868711
[TBL] [Abstract][Full Text] [Related]
33. Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption.
Hidvégi E; Somogyi GP
Pharmazie; 2010 Jun; 65(6):408-11. PubMed ID: 20614687
[TBL] [Abstract][Full Text] [Related]
34. Screening for cannabinoids in blood using EMIT: concentrations of delta-9-tetrahydrocannabinol in relation to EMIT results.
Gjerde H
Forensic Sci Int; 1991; 50(1):121-4. PubMed ID: 1657743
[TBL] [Abstract][Full Text] [Related]
35. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.
Lewis J; Molnar A; Allsop D; Copeland J; Fu S
Int J Legal Med; 2016 Jan; 130(1):147-52. PubMed ID: 26233612
[TBL] [Abstract][Full Text] [Related]
36. Hair analysis for Delta9-tetrahydrocannabinolic acid A--new insights into the mechanism of drug incorporation of cannabinoids into hair.
Auwärter V; Wohlfarth A; Traber J; Thieme D; Weinmann W
Forensic Sci Int; 2010 Mar; 196(1-3):10-3. PubMed ID: 20129747
[TBL] [Abstract][Full Text] [Related]
37. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use.
Musshoff F; Madea B
Ther Drug Monit; 2006 Apr; 28(2):155-63. PubMed ID: 16628124
[TBL] [Abstract][Full Text] [Related]
38. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
[TBL] [Abstract][Full Text] [Related]
39. [Cannabis and automobile driving].
Ménétrey A; Augsburger M; Giroud C; Mangin P
Praxis (Bern 1994); 2001 Aug; 90(34):1398-407. PubMed ID: 11552320
[TBL] [Abstract][Full Text] [Related]
40. The therapeutic use of cannabinoids: Forensic aspects.
Indorato F; Liberto A; Ledda C; Romano G; Barbera N
Forensic Sci Int; 2016 Aug; 265():200-3. PubMed ID: 27038587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
